Status:
SUSPENDED
Exercise and Prevention of Syncope: EXPOSE
Lead Sponsor:
University of Calgary
Conditions:
Syncope
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether eight weeks of exercise performed at an intensity of approximately 65% VO2max will improve symptoms associated with fainting (vasovagal syncope).
Detailed Description
Background: Vasovagal syncope affects 20-30% of the population, and for those who faint recurrently it causes a significant reduction in the quality of life. Although significant progress has been mad...
Eligibility Criteria
Inclusion
- a diagnosis of vasovagal syncope as the cause of loss of consciousness, \>1 lifetime syncope spell preceding enrolment, \>-3 points on the S3 score for structurally normal hearts, \>18 yrs of age with informed consent -
Exclusion
- subjects with a negative Physical Activity Readiness Questionnaire (PARQ), those who are unable to provide informed consent, those with a VO2max \>55ml/kg/min, those who exercise more than 30 minutes per day, 3 times per week, other causes of syncope, individuals with valvular, coronary, myocardial, or conductive abnormality, significant arrhythmia, hypertrophic cardiomyopathy, permanent pacemaker, seizure disorder, heart failure, major chronic cardiovascular disease, or renal dysfunction.
- \-
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00203593
Start Date
March 1 2006
End Date
June 1 2007
Last Update
March 14 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary (Health Sciences Center)
Calgary, Alberta, Canada, T2N 4N1